Impella utilization in high-risk percutaneous coronary intervention (last remaining vessel)
#CardioTwitterCase originally published on Twitter
From a clean puncture to a safe utilization of Impella in high-risk PCI.
This case was originally published on Twitter by @AsherElad
Case description
We present the case of an 87-year-old male with sepsis and type II myocardial infarction who underwent Impella utilization in high-risk PCI.
The patient's RCA and LCX were occluded, and the last remaining coronary vessel was the LAD (and D1) (Figure 1).

Figure 1
The mid-LAD had a tight and heavily calcified lesion. Hence, we elected to use Impella mechanical support device in this high-risk PCI. We used ultrasonography together with micropuncture technic in order to get both accesses for the Impella and the “regular” 7F femoral sheath.
After guiding was placed in the LM coronary artery, a semi-compliant balloon was delivered, but, before we succeed to expand the lesion, the balloon burst. Hence, non-compliant and cutting balloons were also delivered but, again, burst before expanding the lesion (Figure 2 & Video 1).

Figure 2
Finally, we succeeded in expanding the lesion with a shockwave-balloon technique (Video 2). Lastly, a DES was placed and was further expanded with non-compliant balloon (Figure 3).

Figure 3
Throughout the procedure, the patient was hemodynamically stable, with no chest pain. After PCI completion, the femoral sheaths were removed, and haemostasias was achieved, using ProGlide closure devices.
Final remarks
In conclusion, planning high-risk PCI is of paramount importance, especially if there is a “last remaining vessel”. Impella utilization in high-risk PCI might be a good option to treat this kind of patients.
Original tweet and Twitter discussion
87 y.o male with sepsis and severe heavily calcified LAD. Impella, 2 , then shock wave, and finally stent and post dil. With @dannydvir@KamalHamayel4@PCRonline@Sbrugaletta@Ortega_Paz@aayshacader@Anazmicalik@guilbom@hect2701@NicolaRyanI1@DrPascalMeier@w_jygpic.twitter.com/2Z5AyLYg4K
— Elad Asher (@AsherElad) November 6, 2022
Authors
No comments yet!